Aptima® SARS-COV-2 ASSAY CONTROLS, APTIMA, IVD
by Hologic
Ref PRD-07882
Aptima SARS-COV-2 ASSAY CONTROLS, APTIMA, IVD (ASY-16739) is a SARS-CoV-2 nucleic acid IVD (EU IVDR Class B; FDA Class II; FDA product code QQX, Respiratory specimen nucleic acid SARS-CoV-2 test) made by Hologic, registered in EUDAMED on 9 Jul 2026 (Basic UDI-DI 54200455DIAGAPTSARSCOV2CC), cleared under FDA 510(k) K243396 on 13 Feb 2025 and listed in FDA GUDID since 14 Mar 2025 (UDI-DI 15420045517035), active as of 24 Oct 2026.
Active
CE IVDR 510(k)
Valid until
No date given
FDA recalls
None found
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDR EUDAMED | Number54200455DIAGAPTSARSCOV2CC 15420045517035 | Date9 Jul 2026 | StatusActive |
| United States | GUDID listing GUDID | Number15420045517035 | Date14 Mar 2025 | StatusListed |
| United States | FDA 510(k)SESE GUDID | NumberK243396 | Date13 Feb 2025 | StatusActive |
Official records
- EUDAMED public site 54200455DIAGAPTSARSCOV2CC
- AccessGUDID record 15420045517035
- FDA 510(k) database K243396
From the FDA record
- Device description
- Aptima® SARS-CoV-2 Assay Controls Kit.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- EUDAMED Basic UDI-DI 54200455DIAGAPTSARSCOV2CC registered 9 Jul 2026 Active
- FDA 510(k) K243396 decided 13 Feb 2025 Active
- FDA GUDID UDI-DI 15420045517035 listed 14 Mar 2025 Listed
Timeline
- Cleared FDA 510(k) K243396
- Listed FDA GUDID 15420045517035
- Registered EUDAMED 54200455DIAGAPTSARSCOV2CC
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade name
- Aptima SARS-CoV-2 Assay Controls Kit EUDAMEDAptima® GUDID
- Generic name
- SARS-CoV-2 nucleic acid IVD, control
- Device name
- Aptima SARS-CoV-2 Assay
- Model / Ref / Catalog
- PRD-07882 EUDAMEDSARS-COV-2 ASSAY CONTROLS GUDIDAPTIMA GUDIDIVD GUDIDASY-16739 GUDID
- Primary DI / UDI-DI
- 15420045517035
- Basic UDI-DI
- 54200455DIAGAPTSARSCOV2CC
- Unit of use DI
- 05420045517038
- 510(k) Number
- FDA product code
- QQX
- EMDN code
- W0105080899 Controls - inf. immunology - other
- GMDN term
- SARS-CoV-2 nucleic acid IVD, control
- Device class
- Class B EUDAMEDClass II GUDID
- Regulation number
- 866.3981
- EU registration type
- Standard device
- EU market of registration
- Belgium
- GUDID distribution status
- In Commercial Distribution
Truth per registry
| Field | EUDAMED | GUDID |
|---|---|---|
| Model / reference | PRD-07882 | SARS-COV-2 ASSAY CONTROLS, APTIMA, IVD |
| Device class | Class B | Class II |
Similar devices in this category
Other devices filed under CONTROLS - INF. IMMUNOLOGY - OTHER.
- anti-TP Control IM4291323 by Maccura Biotechnology Co., Ltd.
- HSV-2 IgG Control EIM4297328 by Maccura Biotechnology Co., Ltd.
- Multichem ID ToRCH IgG Negative Control 2010-0023 by LGC Clinical Diagnostics, Inc.
- A810 Negative Control 2010-0020 by LGC Clinical Diagnostics, Inc.
- Helix Elite™ Molecular Standards: Inactivated Standard by MICROBIOLOGICS, INC.
- Atellica IM Zika Ab QC 11204648 by Siemens Healthcare Diagnostics Inc.
- Access Toxo IgG QC A31590 by Beckman Coulter, Inc.
- Multichem ID-COVID19 CVG100P by Techno-Path Manufacturing
- ADVIA Centaur Zika Ab QC 11202474 by Siemens Healthcare Diagnostics Inc.
- Vigil Serology Control Level C 465440 by Beckman Coulter, Inc.